Growth Metrics

Westlake Chemical Partners (WLKP) EBITDA Margin (2016 - 2026)

Westlake Chemical Partners filings provide 13 years of EBITDA Margin readings, the most recent being 27.78% for Q4 2025.

  • On a quarterly basis, EBITDA Margin fell 394.0% to 27.78% in Q4 2025 year-over-year; TTM through Dec 2025 was 27.39%, a 698.0% decrease, with the full-year FY2025 number at 27.39%, down 698.0% from a year prior.
  • EBITDA Margin hit 27.78% in Q4 2025 for Westlake Chemical Partners, down from 29.78% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 115.99% in Q1 2022 to a low of 19.47% in Q2 2022.
  • Median EBITDA Margin over the past 5 years was 30.59% (2023), compared with a mean of 34.02%.
  • Biggest five-year swings in EBITDA Margin: soared 8652bps in 2022 and later tumbled -8408bps in 2023.
  • Westlake Chemical Partners' EBITDA Margin stood at 42.6% in 2021, then plummeted by -39bps to 25.97% in 2022, then grew by 20bps to 31.22% in 2023, then rose by 2bps to 31.73% in 2024, then decreased by -12bps to 27.78% in 2025.
  • The last three reported values for EBITDA Margin were 27.78% (Q4 2025), 29.78% (Q3 2025), and 30.71% (Q2 2025) per Business Quant data.